In 2023, Mediclinic Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Mediclinic Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mediclinic Group’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2023, the total operational greenhouse gas (GHG) emissions of Mediclinic Group amounted to 182,898 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Mediclinic Group decreased by 23.38%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b
In 2023, the total Scope 1 emissions of Mediclinic Group were 42,550 metric tons of CO₂ equivalent (tCO₂e). a
Since 2019, Mediclinic Group's Scope 1 emissions have increased by 45.53%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), Mediclinic Group's Scope 1 emissions decreased by 4.51%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b
In 2023, Mediclinic Group reported Scope 2 greenhouse gas (GHG) emissions of 140,348 tCO₂e using the market-based method. a
Since 2019, Mediclinic Group's Scope 2 greenhouse gas (GHG) emissions (Market-Based) have decreased by 33.4%, reflecting a declining long-term trend in Scope 2 emissions over time. a
In 2023, Mediclinic Group reported its Scope 2 emissions using the market-based method. a
In 2023, Mediclinic Group reported 117,128 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of Mediclinic Group includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2023, Mediclinic Group reported total Scope 3 emissions of 117,128 metric tons of CO₂ equivalent (tCO₂e). a
Since 2019, Mediclinic Group's Scope 3 emissions have increased by 98.6%, reflecting a rising long-term trend in Scope 3 emissions over time. a
Compared to the previous year (2022), Mediclinic Group's Scope 3 emissions increased by 60.96%, suggesting that the company faced challenges in reducing emissions across its value chain. a
In 2023, Mediclinic Group reported a total carbon footprint of 300,026 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.67% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output. a b
The largest contributor to Mediclinic Group's total carbon footprint was Scope 2 emissions, accounting for 46.78% of the company's total carbon footprint, followed by Scope 3 emissions at 39.04%. a